Financial News

GRAIL, Inc. - Common Stock (NQ: GRAL )

16.38 +1.29 (+8.55%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Via MarketBeat

3 Spinoff Stocks You Should Buy Now: July 2024

July 15, 2024

Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early.

Via InvestorPlace

3 Biotech Stocks Turning DNA Dreams Into Dollars

July 05, 2024

Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.

Via InvestorPlace

Dear AMZN Stock Fans, Mark Your Calendars for July 16

June 25, 2024

Amazon stock is worth watching for AMZN investors on July 16 as that's when the e-commerce company will start its Prime Day sales.

Via InvestorPlace

Tesla Cybertruck Recalls: What to Know as Tesla Recalls Thousands of EVs

June 25, 2024

The Tesla Cybertruck recalls continue with the electric vehicle (EV) company seeking to repair issues with thousands of the trucks.

Via InvestorPlace

Topics Electric Vehicles Product Recall

Exposures Electric Vehicles Legal Product Safety

Earnings Scheduled For November 12, 2024

November 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session

October 14, 2024

Via Benzinga

European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine

September 03, 2024

Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million...

Via Benzinga

GRAL Stock Earnings: GRAIL Reported Results for Q2 2024

August 15, 2024

GRAIL just reported results for the second quarter of 2024.

Via InvestorPlace

3 Top Cancer Treatment Stocks to Buy Now

July 17, 2024

These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term.

Via InvestorPlace

Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?

July 16, 2024

Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in...

Via Benzinga

Topics Economy Stocks

Exposures Interest Rates US Equities

Why Is SolarEdge (SEDG) Stock Down 17% Today?

June 25, 2024

SolarEdge stock is falling on Tuesday as SEDG investors react to one of the company's customers goin bankruptcy without paying back debts.

Via InvestorPlace

Topics Bankruptcy

Exposures Financial Legal

GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today

June 25, 2024

New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock.

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

GRAIL, Inc. - Common Stock (NQ: GRAL )

All News about GRAIL, Inc. - Common Stock

Popular Pages